Approvals were down last quarter. Vertex (Cambridge, MA, USA) got a green light for its small-molecule combination to combat cystic fibrosis; Theratechnologies (Montreal, Quebec, Canada) and Sun Pharmaceuticals (Mumbai, India) received registrations for monoclonal antibodies (mAbs) to treat HIV and psoriasis, respectively…

Para acessar a publicação na íntegra clique aqui

Fonte: 386 VOLUME 36 NUMBER 5 MAY 2018 NATURE BIOTECHNOLOGY